Geovax Labs (GOVX) Stock Price, Quote & News

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tu...

Industry: Biotechnology

Sector: Healthcare

Phone: 678 384 7220

Fax: 678 384 7281

Website: www.geovax.com

Address:

1900 Lake Park Drive, Suite 380, Smyrna, United States

BiotechGoldenEra May. 13 at 3:56 AM

$GOVX oh the hit virus, rat poop transmission

0 · Reply

Ruddogg21 May. 13 at 2:56 AM

$GOVX Added

0 · Reply

Waffels May. 12 at 9:06 PM

$GOVX

0 · Reply

DeezNuttz May. 12 at 6:16 PM

$GOVX

0 · Reply

Idonno May. 12 at 2:58 PM

$GOVX Possible one of the scammiest scams on WS this company produced nothing and takes investors money unless u r short

0 · Reply

Srmilton May. 11 at 8:34 PM

$GOVX let's see what happens

0 · Reply

Waffels May. 11 at 7:37 PM

$GOVX only the real investors know what is happen here. soon something else will happen and that will be good

1 · Reply

Stopcryin May. 11 at 5:42 PM

$COSM $VRAX $GOVX With Cosm being down almost another 10% how is it possible this will get back to the needed $1 before it is delisted in a few weeks? Has anyone bothered to ask Siokas this question on X? Is it a forgone conclusion a RS will have to be announced in a few weeks?

0 · Reply

CoffeeRocks May. 11 at 5:24 PM

$VRAX $GOVX $COSM $ISPC Orange monster 👺 BiGGest shorter in the market Makes Michael Burry Look like a 💩 🛌 https://www.benzinga.com/news/health-care/26/05/52439918/chuck-schumer-trump-elon-musk-cdc-port-health-workers-hantavirus

0 · Reply

WallStreetVice May. 11 at 2:59 PM

$STKE $TNYA $GOVX $RKLB 73…

0 · Reply

GeoVax Labs price target lowered to $10 from $14 at Roth Capital

2026-04-16T10:11:41.000Z - 27 days ago

GeoVax Labs files to sell 1.27M shares of common stock for holders

2026-04-16T10:10:12.000Z - 27 days ago

GeoVax Labs files to sell 865,804 shares of common stock for holders

2026-02-19T13:49:42.000Z - 2 months ago

GeoVax Labs downgraded to Hold from Buy at D. Boral Capital

Jan 13, 2026, 5:30 PM EST - 4 months ago

GeoVax Labs Transcript: Biotech Showcase 2026

2026-01-10T00:50:28.000Z - 4 months ago

Geovax Labs Inc trading halted, news pending

2025-12-12T22:30:17.000Z - 5 months ago

GeoVax Labs files to sell 18.29M units

Nov 13, 2025, 4:30 PM EST - 6 months ago

GeoVax Labs Earnings Call Transcript: Q3 2025

2025-10-17T20:45:13.000Z - 7 months ago

GeoVax Labs files to sell 11.9M shares of common stock for holders

Sep 25, 2025, 3:55 PM EDT - 8 months ago

GeoVax Labs Transcript: Emerging Growth Conference 2025

Sep 8, 2025, 7:00 AM EDT - 8 months ago

GeoVax Labs Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Aug 20, 2025, 3:40 PM EDT - 9 months ago

GeoVax Labs Transcript: Emerging Growth Conference 85

2025-08-07T18:45:57.000Z - 9 months ago

HHS mRNA vaccine decision bodes well for GeoVax Labs, says Roth Capital

Jul 28, 2025, 4:30 PM EDT - 10 months ago

GeoVax Labs Earnings Call Transcript: Q2 2025

2025-07-24T18:10:23.000Z - 10 months ago

Meet GeoVax Labs: Fly exclusive interview with CEO David Dodd

2025-07-24T18:05:45.000Z - 10 months ago

GeoVax Labs CEO says current political climate ‘highly favorable’

2025-06-17T14:35:23.000Z - 11 months ago

GeoVax’s EMA guidance provides clear pathway, says Alliance Global Partners

2025-06-16T20:45:13.000Z - 11 months ago

GeoVax Labs files to sell 6.15M common units

2025-06-16T15:00:08.000Z - 11 months ago

GeoVax Labs receives favorable European regulatory guidance supporting GEO-MVA

May 1, 2025, 4:30 PM EDT - 1 year ago

GeoVax Labs Earnings Call Transcript: Q1 2025

2025-04-15T17:15:09.000Z - 1 year ago

Roth says BARDA stopping funding for GeoVax COVID trial similar to peers

Mar 27, 2025, 4:30 PM EDT - 1 year ago

GeoVax Labs Earnings Call Transcript: Q4 2024

Feb 19, 2025, 2:55 PM EST - 1 year ago

GeoVax Labs Transcript: Emerging Growth Conference 79

Jan 16, 2025, 2:35 PM EST - 1 year ago

GeoVax Labs Transcript: Emerging Growth Conference 78

Dec 9, 2024, 9:00 AM EST - 1 year ago

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Nov 26, 2024, 9:00 AM EST - 1 year ago

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

Nov 12, 2024, 4:30 PM EST - 1 year ago

GeoVax Labs Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:00 PM EST - 1 year ago

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 5, 2024, 9:00 AM EST - 1 year ago

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

Oct 2, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Sep 9, 2024, 7:00 AM EDT - 1 year ago

GeoVax Labs Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 3, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Participate in Upcoming Investor Conferences in September

Aug 28, 2024, 8:59 PM EDT - 1 year ago

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

Aug 20, 2024, 8:09 AM EDT - 1 year ago

GeoVax's stock slides 20% after company raises $8.5 million in stock sale

Aug 20, 2024, 7:45 AM EDT - 1 year ago

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Aug 20, 2024, 7:00 AM EDT - 1 year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS IMRN

Aug 19, 2024, 7:30 AM EDT - 1 year ago

GeoVax's stock soars 54% to lead rally in companies developing mpox treatments

Aug 15, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

Aug 15, 2024, 8:36 AM EDT - 1 year ago

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

EBS SIGA

Aug 8, 2024, 9:00 AM EDT - 1 year ago

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

Aug 6, 2024, 4:30 PM EDT - 1 year ago

GeoVax Labs Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:00 PM EDT - 1 year ago

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Jul 31, 2024, 10:15 AM EDT - 1 year ago

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

May 14, 2024, 4:30 PM EDT - 2 years ago

GeoVax Labs Earnings Call Transcript: Q1 2024

Apr 4, 2024, 12:30 PM EDT - 2 years ago

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

Mar 28, 2024, 9:00 AM EDT - 2 years ago

GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

Mar 18, 2024, 5:30 PM EDT - 2 years ago

GeoVax Labs Transcript: Roth MKM 36th Annual ROTH Conference

Mar 12, 2024, 9:00 AM EDT - 2 years ago

GeoVax to Present at the 36th Annual Roth Conference

Mar 6, 2024, 9:00 AM EST - 2 years ago

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

Feb 29, 2024, 4:30 PM EST - 2 years ago

GeoVax Labs Earnings Call Transcript: Q4 2023

Feb 29, 2024, 4:00 PM EST - 2 years ago

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

Feb 22, 2024, 9:00 AM EST - 2 years ago

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

Feb 19, 2024, 9:00 AM EST - 2 years ago

GeoVax to Present at the 2024 BIO CEO & Investor Conference

Feb 13, 2024, 9:00 AM EST - 2 years ago

GeoVax Announces Multiple Patent Issuances and Allowances

Feb 6, 2024, 9:00 AM EST - 2 years ago

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

Jan 29, 2024, 9:00 AM EST - 2 years ago

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Jan 8, 2024, 5:30 PM EST - 2 years ago

GeoVax Labs Transcript: J.P. Morgan 42nd Annual Healthcare Conference 2024

Jan 8, 2024, 9:00 AM EST - 2 years ago

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

Jan 4, 2024, 9:00 AM EST - 2 years ago

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

Jan 3, 2024, 9:00 AM EST - 2 years ago

GeoVax Announces Issuance of Malaria Vaccine Patent

Dec 27, 2023, 9:00 AM EST - 2 years ago

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

Dec 19, 2023, 9:00 AM EST - 2 years ago

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

Nov 30, 2023, 4:30 PM EST - 2 years ago

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

Nov 29, 2023, 9:00 AM EST - 2 years ago

GeoVax to Participate in Upcoming December Investor Events

Nov 28, 2023, 9:00 AM EST - 2 years ago

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Nov 14, 2023, 9:00 AM EST - 2 years ago

Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

Nov 8, 2023, 4:30 PM EST - 2 years ago

GeoVax Labs Earnings Call Transcript: Q3 2023

Nov 8, 2023, 4:00 PM EST - 2 years ago

GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update

Oct 30, 2023, 9:00 AM EDT - 2 years ago

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine

Oct 25, 2023, 9:00 AM EDT - 2 years ago

GeoVax to Participate in Upcoming November Investor and Industry Events

Oct 24, 2023, 9:00 AM EDT - 2 years ago

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

Oct 9, 2023, 9:00 AM EDT - 2 years ago

GeoVax Receives Notice of Allowance for Marburg Vaccine Patent

Oct 5, 2023, 9:00 AM EDT - 2 years ago

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

Sep 27, 2023, 9:00 AM EDT - 2 years ago

GeoVax to Participate in Upcoming October Investor and Industry Events

Sep 20, 2023, 9:00 AM EDT - 2 years ago

GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference

Sep 19, 2023, 9:00 AM EDT - 2 years ago

GeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients

Sep 12, 2023, 9:00 AM EDT - 2 years ago

GeoVax Presents Corporate Update at the H.C. Wainwright 25th Annual Global Investment Conference

Sep 11, 2023, 9:00 AM EDT - 2 years ago

GeoVax Completes Enrollment of Phase 2 Trial for Next-Generation COVID-19 Vaccine Booster

Aug 31, 2023, 9:00 AM EDT - 2 years ago

GeoVax to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 29, 2023, 9:00 AM EDT - 2 years ago

GeoVax to Present at the Emerging Growth Conference on September 6, 2023

Aug 28, 2023, 9:00 AM EDT - 2 years ago

GeoVax Receives Notice of Allowance for Malaria Vaccine Patent

Aug 10, 2023, 9:00 AM EDT - 2 years ago

GeoVax Announces First Patients Vaccinated in Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia

BiotechGoldenEra May. 13 at 3:56 AM

$GOVX oh the hit virus, rat poop transmission

0 · Reply

Ruddogg21 May. 13 at 2:56 AM

$GOVX Added

0 · Reply

Waffels May. 12 at 9:06 PM

$GOVX

0 · Reply

DeezNuttz May. 12 at 6:16 PM

$GOVX

0 · Reply

Idonno May. 12 at 2:58 PM

$GOVX Possible one of the scammiest scams on WS this company produced nothing and takes investors money unless u r short

0 · Reply

Srmilton May. 11 at 8:34 PM

$GOVX let's see what happens

0 · Reply

Waffels May. 11 at 7:37 PM

$GOVX only the real investors know what is happen here. soon something else will happen and that will be good

1 · Reply

Stopcryin May. 11 at 5:42 PM

0 · Reply

CoffeeRocks May. 11 at 5:24 PM

0 · Reply

WallStreetVice May. 11 at 2:59 PM

$STKE $TNYA $GOVX $RKLB 73…

0 · Reply

jacksparo May. 11 at 1:36 AM

$SLS $IBRX $GOVX $NRXP $GUTS I am preparing multiple rounds of plans about some important biotech stocks! All my Live updates always shared in my Live Biotech group! Stay tuned for a hot summer in multiple biotech stocks!

0 · Reply

CROW_D May. 9 at 11:51 PM

$AEMD Setting up for next week Fits the theme potential monday runner Strategic Review Update Anytime (Q2/Q3 2026) High (Could lead to a buyout Oncology Cohort 3 Progress Mid-to-Late 2026 Medium (Builds long-term credibility) Hantavirus PR/News Immediate (May 2026) High Volatility (Fast up, fast down) Q4 Earnings Report Late June 2026 Medium (Financial health check) $GOVX $CODX watching aswell

0 · Reply

SPARTANVI May. 9 at 9:58 PM

$AEMD ⏰️🔥👇 nice potential with catalyst Strategic Review Update Anytime (Q2/Q3 2026) High (Could lead to a buyout Oncology Cohort 3 Progress Mid-to-Late 2026 Medium (Builds long-term credibility) Hantavirus PR/News Immediate (May 2026) High Volatility (Fast up, fast down) Q4 Earnings Report Late June 2026 Medium (Financial health check) Also watching $VRAX $GOVX

0 · Reply

SavageJohnny May. 9 at 8:46 PM

$AMS The way it's moving right now tells me we have news coming. Very much likely we could get one next week, it's going to be a cherry on top. Liking these tickers as well $GOVX $VRAX $AEMD and $RXT good looks.../

0 · Reply

PyroMatic May. 9 at 7:40 PM

$AMS Launch next week. People Iove 5 Mins trader I love a nice swing. This continues to go up like a champ! AMS sexy looking. China mania was fun Friday, got to bank on $AEHL also watching $VRAX $AEMD $GOVX .

0 · Reply

JasonNewton May. 9 at 7:25 PM

AMS is moving from an investment-heavy phase into a revenue-harvesting phase. The combination of: * expanding treatment centers, * rising direct patient revenue, * improving utilization, * international growth hopes, * and an extremely low float AMS hot watch. $VRAX $GOVX w/

0 · Reply

DeezNuttz May. 8 at 10:26 PM

$GOVX

0 · Reply

amcgmeape6969 May. 8 at 10:06 PM

$SIGA $GOVX made big bills on these two during the monkey poxx days. can we do something with this hanta virus sht going around?🤪🤪🤪🤪

1 · Reply

GreenBull4ever88 May. 8 at 1:28 AM

$GOVX Was this that Monkey Pox Vaccine stock?!! 🙏

0 · Reply

topstockalerts May. 8 at 1:21 AM

$GOVX this is why patience actually pays sometimes

0 · Reply

topstockalerts May. 8 at 1:20 AM

$GOVX part of me thinks it’s extended, part of me thinks it’s just starting 🤔

1 · Reply

geniuscali May. 7 at 10:10 PM

$GOVX 🤣🤣🤣🤣🤣 Still zero product. More dilution then RS. Whos is dumb enough to buy this garbage

0 · Reply

Market Cap	6.22M
Revenue (ttm)	3.95M
Net Income (ttm)	-24.99M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-632.66%
Debt to Equity Ratio	0.00

Volume	3,206,649
Avg Vol	2,079,406
Day's Range	N/A - N/A
Shares Out	30.06M
Stochastic %K	68%
Beta	3.67
Analysts	Strong Sell
Price Target	$9.62